Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-28
DOI
10.1038/s41467-018-06177-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition
- (2017) Yinan Li et al. EUROPEAN UROLOGY
- SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer
- (2017) Ping Mu et al. SCIENCE
- Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
- (2017) Sheng Yu Ku et al. SCIENCE
- N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer
- (2016) Etienne Dardenne et al. CANCER CELL
- Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas
- (2016) Brittany Kleb et al. Epigenetics
- Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
- (2016) Akash Kumar et al. NATURE MEDICINE
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1
- (2016) M Hulsurkar et al. ONCOGENE
- The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
- (2016) Jennifer L. Bishop et al. Cancer Discovery
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer
- (2015) X. Zhang et al. CLINICAL CANCER RESEARCH
- SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2
- (2015) Kimberly H Kim et al. NATURE MEDICINE
- RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
- (2015) Matthew J. Niederst et al. Nature Communications
- The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
- (2015) Shusuke Akamatsu et al. Cell Reports
- Polycomb-mediated silencing in neuroendocrine prostate cancer
- (2015) Pier-Luc Clermont et al. Clinical Epigenetics
- Targeting Neuroendocrine Prostate Cancer: Molecular and Clinical Perspectives
- (2015) Panagiotis J. Vlachostergios et al. Frontiers in Oncology
- Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy
- (2014) Alvaro Aytes et al. CANCER CELL
- Chromatin Repressive Complexes in Stem Cells, Development, and Cancer
- (2014) Anne Laugesen et al. Cell Stem Cell
- Aggressive Variants of Castration-Resistant Prostate Cancer
- (2014) H. Beltran et al. CLINICAL CANCER RESEARCH
- Angiogenesis and vascular maturation in neuroendocrine tumors
- (2014) Samaneh Yazdani et al. HUMAN PATHOLOGY
- Meta-analysis of the effects of beta blocker on survival time in cancer patients
- (2014) Chel Hun Choi et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Neuroendocrine Prostate Cancer (NEPC) Progressing From Conventional Prostatic Adenocarcinoma: Factors Associated With Time to Development of NEPC and Survival From NEPC Diagnosis—A Systematic Review and Pooled Analysis
- (2014) Hai Tao Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Antihypertensive medications and survival in patients with cancer: A population-based retrospective cohort study
- (2013) Signy Holmes et al. Cancer Epidemiology
- EZH2, an epigenetic driver of prostate cancer
- (2013) Yeqing Angela Yang et al. Protein & Cell
- EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis
- (2012) Francesco Crea et al. CANCER AND METASTASIS REVIEWS
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
- (2012) K. Xu et al. SCIENCE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- BMP4 Promotes Prostate Tumor Growth in Bone through Osteogenesis
- (2011) Y.-C. Lee et al. CANCER RESEARCH
- Molecular Pathways: Beta-Adrenergic Signaling in Cancer: Figure 1.
- (2011) Steven W. Cole et al. CLINICAL CANCER RESEARCH
- Modeling a Lethal Prostate Cancer Variant with Small-Cell Carcinoma Features
- (2011) V. Tzelepi et al. CLINICAL CANCER RESEARCH
- FGF-2 Regulates Cell Proliferation, Migration, and Angiogenesis through an NDY1/KDM2B-miR-101-EZH2 Pathway
- (2011) Filippos Kottakis et al. MOLECULAR CELL
- Using β-blockers to inhibit breast cancer progression
- (2011) Desmond G. Powe et al. Nature Reviews Clinical Oncology
- EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin
- (2011) Z-T Tong et al. ONCOGENE
- Neuroendocrine tumor cells in prostate cancer: Evaluation of the neurosecretory products serotonin, bombesin, and gastrin - impact on angiogenesis and clinical follow-up
- (2011) Elmar Heinrich et al. PROSTATE
- Understanding the Lethal Variant of Prostate Cancer: Power of Examining Extremes
- (2011) A. Aparicio et al. Cancer Discovery
- Regulation of Tumor Angiogenesis by EZH2
- (2010) Chunhua Lu et al. CANCER CELL
- Roles of cAMP and cAMP-dependent protein kinase in the progression of prostate cancer: Cross-talk with the androgen receptor
- (2010) Dennis Merkle et al. CELLULAR SIGNALLING
- Androgens Suppress EZH2 Expression Via Retinoblastoma (RB) and p130-Dependent Pathways: A Potential Mechanism of Androgen-Refractory Progression of Prostate Cancer
- (2010) Laura R. Bohrer et al. ENDOCRINOLOGY
- An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB
- (2010) Junxia Min et al. NATURE MEDICINE
- VEGF Secretion by Neuroendocrine Tumor Cells Is Inhibited by Octreotide and by Inhibitors of the PI3K/AKT/mTOR Pathway
- (2010) Karine Villaume et al. NEUROENDOCRINOLOGY
- The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer
- (2010) J Yu et al. ONCOGENE
- E2F-1 Directly Regulates Thrombospondin 1 Expression
- (2010) Wei Ji et al. PLoS One
- Mechanisms of Polycomb gene silencing: knowns and unknowns
- (2009) Jeffrey A. Simon et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence
- (2008) Jason M. D'Antonio et al. PROSTATE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started